A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.


Updates from The Motley Fool

Latest updates on Novavax from Fool.com.  The Fool has written over 100 articles on Novavax.
Novavax, Inc.: Buy the Dip?

Novavax's stock recently fell after the company shared a few positive updates. Is this a smart ti...

Why Novavax, Inc Is Tanking Today

Shares are plunging after the clinical-stage vaccine maker provided investors with a slew of clin...

3 Stocks to Avoid in Biotech

Biotech stocks are known for their high growth, but they can also be toxic for your portfolio if ...

2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...



Stock Performance

View Interactive NVAX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novavax.
Current Price: $1.00
Prev Close: $0.99
Open: $0.97
Bid: $1.00
Ask: $1.02
Day's Range: $0.97 - $1.01
52wk Range: $0.73 - $8.49
Volume: 2,716,260
Avg Vol 8,669,902
Market Cap: $294M
P/E (ttm): -1.29
EPS (ttm): ($0.77)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Novavax.
CAPS Rating 2 out of 5
 
303 Outperform
84 Underperform
CAPS All Stars
 
40 Outperform
15 Underperform

How do you think Novavax will perform against the market?



You pick for Novavax is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Stanley C. Erck, CEO

71% Approve

Based on 31 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novavax.

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers